DYRK1A and glioblastoma: In support of the DYRK1A-CDC23 axis controlling glioblastoma cell cycle, CDC23 knockdown increased the percentage of Ki67-positive cells, the number of mitotic figures and overall cell numbers (Fig. 4G–I).